Aerosols of a physiological salt solution and aqueous solutions o f salbutam ol, sodium crom oglicate, and dornase aifa were generated in a pneum atic nebulizer and analyzed in a system with controlled hum idity of a ir as a carrier gas. Mass d istrib u tio n of aerosol particles and yield of generation fo r pulse nebulization were measured. P ulsation of generation was realized w ith an attachm ent m aintained by a com puter program . O pening times of the valve were in the range 50-800 ms. The results indicate the possibility of im proving aerosol particle delivery to the lung using a pulse generation system. in h a la tio n nebulizer flow pulsation
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INTRODUCTION
Recent epidemiological studies indicate health effects on the general population at air particulate mass concentrations that are considerably below existing air quality standards (Roth, Wyzga, & H ayter, 1986) . These new data indicate that an increase in hum an m ortality and m orbidity is associated with levels of air particulate pollution. The synergetic effect of the reaction of deposited particles and inhaled harm ful gases in the pulm onary region of hum an lungs can significantly change the mechanical properties o f lung parenchyma.
Correspondence and requests for reprints should be sent to Leon Gradori, Department of Chemical and Process Engineering, Warsaw University of Technology, ul. Waryriskiego 1, 00-645 W arszawa, Poland. E-mail: < gradon@ ichip.pw .edu.pl> .
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New observations, experimental results, and hypotheses underline the role o f very fine insoluble particles with dimensions smaller and much smaller than 1 pm , mainly particles in the size range between 10 and 50 nm, which are now of interest to toxicologists (Heinrich, 1995) . A lthough these particles have very low mass, there are extremely many of them and their sheer numbers mean that they present a large surface and interface when they reach the alveoli in the lung. Once in the alveoli, they may induce oxidant production, lung inflam mation, and biological activity. Lung diseases caused by long-term exposure to particulate or gaseous pollutants at the workplace, like emphysema, asthm a, or fibrosis, require efficient medical treatment.
A erosolotherapy is one of the best methods of treating lung diseases. M odern m ethods of aerosolized particle detection allow precise measure m ent of particles smaller than 1 pm. Currently, experimental and theo retical analyses of deposition focus on particles of such dimensions.
A theoretical model concerning the efficiency of aerosolized particle deposition in peripheral bronchiole and alveoli (G radon & Podgorski, 1996) in healthy hum an has shown that for particles 0.1-0.5 pm big, local deposition efficiency in that area ranges around 30-50% . Taking into consideration how easily submicron particles penetrate the peripheral part of the respiratory system and the fact that the deposition of particles heavily depends on diffusion-a mechanism equally efficient in both inspiration and expiration phases-it may turn out that particle production from such a range of dimensions will be of great im portance in aerosolotherapy. This has also been confirmed by the results of experimental tests. M ason and Miller (1994) , with the help of a gamma camera, measured the deposition efficiency of physiological salt's aerosol particles m arked with technetium "T c. Tests were carried out on 9 patients using two types of pneum atic nebulization means. In the first case, the average mass diameter of the generated particles was 1.45 /im; in the second case-modified by the use of a special uni-directional valve-the average mass diameter was 0.55 nm. The tests have shown that an average full mass deposition efficiency in the peripheral part of a lung counted in relation to the generated pharm aceutical's mass was about 8% in the first case, with 5% of particle penetration into the digestive system, whereas in the second case, deposition efficiency was about 19% and penetration into the digestive system was about 1%. Taking into consideration the conditions of the experiment (times of inhalation and
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of measurement) and the analysis of retention curves (G radon & Podgorski, 1996) , it turns out that for a spectrum of particles with an average diameter of 1.45 fim, their m ajority is deposited in the nasopharynx and the upper airways, where they are easily removed into the digestive system during mucociliary transport.
F or a spectrum of particles with an average diameter of 0.55 /im, m ost particles are deposited in peripheral bronchiole and alveoli, where clearance efficiency is much smaller than in the bronchial tree. Hence such low penetration of this type of particles into the digestive system through clearance mechanisms in the airways of the respiratory system.
An extended model of deposition for pathological cases, taking into account the specific movement of the alveolar m embrane (i.e., in asthm a or emphysema) in respect to the flow pattern of inhaled air (Orlicki & G radon, 1996) , has shown that in such cases the efficiency of submicron particle deposition is equally high. This is due to strong convection near the walls of the airways and enhancement of the deposition effect in the convective diffusion process. The aforementioned data point to the fact that submicron particles have a considerable influence on deposition and can be used in aerosolotherapy providing that such particles can be generated and their dimensions stabilized (G radon, 1997). As a fraction of submicron particles that have not been deposited is easily exhaled, there is a problem of their interaction with inhaled particles during the next inspiration phase of the breathing cycle. In order to avoid such a situation, it would be advisable to apply a pharm aceutical into the respiratory system during the inspiration phase divided into an active phase (generation of a pharmaceutical) and a passive phase (no generation of a pharmaceutical). This may improve the overall treatm ent effect, that is, increase the effective am ount of the pharm aceutical delivered to the peripheral part of a lung. However, there are questions of how to control the pulse generation of the pharm aceutical and of whether the generated aerosol has an appropriate dispersion distribution.
To allow measurement of this type, an experimental model was built. A control attachm ent that provides a pulse m ethod of opening a valve that stops the air flow from the compressor to the aerosol generator (nebulizer) is the main element of the model. The time and frequency of the opening may be m aintained by a com puter and synchronized by a breathing simulation signal. The objective of the presented investi gation is to analyze the characteristics of a Sidestream nebulizer, that is, the efficiency and mass distribution of the particles generated with the pulse m ethod from a physiological salt solution, salbutam ol, sodium cromoglicate, and dornase alfa aqueous solutions.
METHOD
F ig u re 1. E x p e rim e n ta l setup. Notes. 1-dilu tio n chamber, 2-fibrous hum idifier, 3-a ir filter, 4-air compressor, 5-PNEUMONEB® attachm ent (artmed Ltd., Poland), 6-Sidestream nebulizer, 7-com puter, 8-sam pling probe, 9-air filter, 10-A3 laser aerosol counter, 11-hum idifier.
The studies were carried out in the experimental setup presented in Figure 1 . Em ployment of the aerosol analyzer A3 (10; A3 G m bH , G ermany) required-like the use of other laser meters-an appropriate dissolving of the generated aerosol. This was done with a cylindrical dilution chamber (1) fed with atmospheric air passing the absolute filter (3). To eliminate aerosol evaporation on its way to the analyzer, the air was humidified on flow through a fibrous humidifier (2) m ounted in the inlet of the chamber. A Sidestream nebulizer (6) was supplied by a mechanical compressor (4; Medic-Aid Ltd., UK) through a controlling attachment PNEUM ONEB® (5; artmed Ltd., Poland). It was maintained by com puter software PN EU M O RS (artmed Ltd., Poland) from a personal com puter (7). Sampling of the aerosol by the particle counter was done automatically through an isokinetic glass probe (8). Before the sample reached the counting means of the A3 device, it was additionally diluted with the air passing through the humidifier (11) and the absolute filter (9).
Param eters of the diluting air stream were periodically measured with a digital therm om eter and a Tri Sense hygrometer (Cole Palmer, USA). The experiments were carried out at room temperature (25 + 1 °C) and at the relative humidity of the diluting air ranging from 75 to 85%. The nebulizer efficiency in different programs controlled by the attachment was estimated on the basis of the liquid mass deficit at time intervals during the process of aerosol generation. The size distribution of the generated droplets was measured by the aerosol counter in the range 0.3-10 fim. Each measurement was preceded by 120 s of idle time needed for stabilization of the conditions in the mixing chamber and the probe line. Each type of measurement was independently repeated three to five times.
RESULTS
In the first stage of the measurements, 10 Sidestream nebulizers were tested to evaluate their efficiency (i.e., rate o f aerosol production) in continuous generation and change in efficiency during nebulization. The aerosolized liquid was a physiological salt solution. Test results are shown in Table 1 and Figure 2 . Some differences among 10 units of the same type of nebulizer can be observed, probably as a result of small differences in the construction of im portant elements of the nebulizer (e.g., the nozzle or the impact plane), which may originate in the m anufacturing process. A part from nebulizers m arked A and D, all tested devices had generation rates between 0.12 and 0.15 g/min. Figure 2 shows that mass loss during generation is constant (the nebulizer's efficiency remains unchanged) for about 1 hr of nebulization. Then, the generation rate decreases, which is a consequence of the fact that the nebulizer runs out o f liquid (only single dripping droplets reach the nozzle).
T A B L E 1. G e n e ra tio n Rate of S id e s tre a m N e b u lize rs S u p p lie d w ith a C ontinuous
D uring the second stage of testing, the influence of the nebulizer's pulse supply on the nebulization rate and the droplet size distribution were measured. One type of pulsation was used according to the following formula: Test results of droplet mass distribution obtained in both methods of aerosol generation are shown in Figures 4-7 .
The last part of the project focused on a detailed test of the influence of the pulse supply m ethod on droplet size distribution of a physiological salt solution aerosol. Supplying nebulizers with air was based upon the following formula: n repetitions t 0 ms / rc ms, and a final interval y ms, where t " stands for time of valve opening (air flow to nebulizer), and xc and Tf denote times when the valve was closed. A complete series of impulses was emitted in time Ttotai ms and was repeated 200 times. The tested variants of pulse generation are presented in Table 3 . The influence of pulse generation on droplet size distribution is presented in Table 4 and, collectively, in Figure 8 .
T A B L E 4.
M ass D istrib u tio n of Physio lo g ical S alt A e ro so l in D ifferen t V a ria n ts of P u ls e G e n e ra tio n 
DISCUSSION OF RESULTS
The generation rate for substances (pharmaceuticals) generated in continu ous nebulization changes from about 0.3 g/min (salbutamol) to about 0.15 g/min (NaCI solution). In this generation method, nebulization efficiency depends mainly on the nozzle construction and pressure. For the same type of generators, differences appear as a result of different liquid viscosity and especially surface tension of a liquid from which the aerosol is generated. A smaller efficiency difference is observed in pulse aerosol generation because the time of droplet form ation in relation to the time of opening the valve generating the pressure impulse comes into play. D ue to this effect, the generation rate is stabilized by the pulse m ethod. The dimension distribution in generated particles for both continuous and impulse m ethods is similar. For a valve opening exceeding 100 ms, the impulse m ethod provides an additional advantage. In the pulse m ethod, at opening times exceeding 100 ms, there is an increase in the mass percentage (15% on average) of particles of 0.5 /im and more. This creates a higher mass fraction of the pharmaceutical delivered to pulm onary alveoli.
On the basis of a formerly prepared model of aerosol particle deposition and inhaled aerosol dispersion, it turns out that the pulse m ethod of dosing a pharmaceutical m ay appear m ore efficient than the continuous m ethod when using an appropriate strategy. Assuming that the valve opening time (an impulse duration) equals 100 ms, generation efficiency of salbutamol, for example, is 0.12 mg per impulse. Furthermore, if we assume that the time of one single inspiration is 2 s and this phase is divided into a 10-impulse sequence at 100 ms intervals during which a patient inhales clean air, then 1.2 mg of the pharmaceutical per inspiration will be delivered to lungs. Considering the am ount of the pharm aceutical delivered per one inspiration, it is possible to program the num ber of inspirations in order to deliver the therapy required dose. The suggested m ethod may considerably improve pharmaceutical deposi tion in lungs, not to mention better supervision of the pharmaceutical.
